Frontier IP Group Plc Bosch UK to work with Pulsiv Solar

Frontier IP Group Plc (LON:FIPP), a specialist in commercialising university intellectual property, today announces that Robert Bosch Limited has entered into an agreement to work with portfolio company Pulsiv Solar to optimise the design of the Company’s energy-efficient solar micro-inverter prototype. Frontier IP holds an 18.9 per cent stake in Pulsiv.

Frontier IP chief executive officer Neil Crabb said: “We are very pleased with the progress Pulsiv Solar is making. This agreement with Bosch supports validation of the Company’s patented photovoltaic inverter technology and we are looking forward to developments across other applications in the future.”

When the prototype moves into full-scale production University of Plymouth spin-out Pulsiv will be able to market the devices as “Engineered by Bosch.” Bosch UK is a subsidiary of Robert Bosch GmbH (“Bosch”), a leading global supplier of technology and services that employs roughly 410,000 associates worldwide.

Solar micro-inverters are plug-in devices that convert direct current (DC) electricity generated by photovoltaic cells to alternating current (AC) used in electrical grids. In laboratory conditions, Pulsiv has demonstrated its technology is significantly more energy efficient than existing micro-inverters.

For the commercial product, the Company is targeting an improvement on energy delivered to the grid of at least 5 per cent over current market leaders. Its micro-inverters can be used in new installations or retrofitted to existing solar panels.

The work with Bosch UK will be funded by the Company as part of a £288,732 project backed by a £129,929 grant from Innovate UK, the UK’s innovation agency.

Other applications being explored for the technology include improving the energy efficiency of power converters used in a huge range of consumer devices, such as televisions, mobile phones and laptops.

Pulsiv was incorporated to develop and commercialise the work of Dr Zaki Ahmed, Associate Professor in Information Technology at the School of Computing, Electronics and Mathematics at the University.

Mahesh Chikodi, UK country head of Robert Bosch Engineering and Business Solutions, said:

“Bosch is currently engaged with Pulsiv Solar for industrialisation of their solution which increases the power output from solar panels. Pulsiv has technology which increases the output of solar panels by up to 30 per cent and Bosch with its leading engineering expertise on software and sensors will aim to accelerate the product development and testing.”

Pulsiv Solar technical director Dr Zaki Ahmed said: “We are very excited to have Bosch’s collaboration and support on the industrialisation of our micro-inverter, and potentially other products. This collaboration means I expect Pulsiv will be able to deliver an average improvement of more than 5 per cent in the energy exported to the electrical grid. We have been assured by a global leader in the renewables space that this improvement could be disruptive to the industry.”

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    Frontier IP Group Plc

    More articles like this

    Frontier IP Group Plc

    Animal Lovers and Zoonotic Diseases: 5 Things to Know

    Zoonotic diseases, or zoonoses, are on the rise. That may first bring to mind exotic diseases like Ebola, but the reality is that many zoonotic infections happen closer to home, often during everyday activities. In 2018,

    Frontier IP Group Plc

    AI-based initiatives catalyzing immunotherapy in 2018

    Artificial intelligence (AI) has been dynamically changing the field of drug discovery in several areas, including immunotherapy, oncotherapy, neurological disease, and many more. Described here is an ensemble of the initiatives in place to advance the field of

    Frontier IP Group Plc

    Frontier IP Group Plc appoint N+1 Singer as sole broker

    Frontier IP Group PLC (LON:FIPP), a specialist in commercialising university intellectual property, today announced the appointment of Nplus1 Singer Advisory LLP as the Group’s sole broker with immediate effect. Allenby Capital Limited remains the Group’s Nominated Adviser.

    Frontier IP Group Plc

    Britain’s university spinout sector is thriving

    They are among Britain’s greatest national treasures and a powerful engine of ideas and innovation for the nation’s booming technology industry. But how good are UK universities at commercialising the research and expertise which springs from

    Frontier IP Group Plc

    Exscientia CEO explains how AI is transforming drug discovery

    In recent decades a strange confluence has formed in the pharmaceutical industry. A range of powerful technologies have brought enormous new capabilities to the sector, productivity has been simultaneously declining. Deloitte’s Centre for Health Solutions estimates that projected returns on investment

    Frontier IP Group Plc

    How technology is revolutionising the healthcare industry

    A technology revolution is transforming the healthcare industry, changing everything from how patients are diagnosed and treated to our battle against some of the world’s most serious diseases. It’s a revolution fuelled by new sources of

    Frontier IP Group Plc

    Artificial Intelligence will Revolutionise Drug Discovery

    New technologies are making their way into the healthcare industry and healthcare providers are already experimenting with advances such as smart pill technology, 3D-printed medication, and mobile apps. But probably the biggest potential lies in artificial intelligence

    Frontier IP Group Plc

    Rallybio forges joint venture with U.K. tech firm

    A Farmington biotech startup formed by a trio of former top Alexion executives said it is working on drug discovery with an artificial intelligence company in the United Kingdom. Rallybio, focused on rare diseases, has not yet publicly

    Frontier IP Group Plc

    What is leptospirosis and how can it harm us and our pets?

    Recently reported cases of the often fatal bacterial infection leptospirosis in dogs in Sydney have raised the issue of animal diseases that also affect humans. This zoonotic disease is spread by rats and other rodents. However, this

    Frontier IP Group Plc

    The Robot Uprising Is Here

    The robot uprising is inevitable. Take the world’s first raspberry-picking robot, an autonomous machine that’s in development by Fieldwork Robotics at the University of Plymouth in the UK. This fruit-picking Terminator, so to speak, was developed for

    Frontier IP Group Plc

    The UK’s 50 Most Disruptive Companies Revealed

    After receiving applications from a wide range of early stage and more established companies from across industries, the initial list was whittled down to 100 by D/SRUPTION. The list was then submitted to an expert judging

    Frontier IP Group Plc

    Artificial intelligence in the world of drug discovery

    Charlotte Walker-Osborn, a Partner and Head of Technology Sector (International) at global law-firm Eversheds Sutherland and a legal expert in technology law, explains some of the challenges and potential future of artificial intelligence (AI) in the

    Frontier IP Group Plc

    11 diseases which can cause infection

    Illnesses that can pass from animals to humans are known as zoonotic. They’re surprisingly common: More than six out of every 10 known infectious diseases in people are actually contracted from animals, according to the CDC.